Epigenomics AG (ECX) | Finanzwire

Basculer en Français

8296	Companies
114905	Keywords
55332	Articles
62461	Press releases

Home
Companies
Epigenomics AG

BRIEF

published on 04/30/2024 at 15:05, 6 months 20 days ago

Epigenomics AG Announces Departure of Executive Board Member Jens Ravens

Executive Board Epigenomics AG Asset Transfer Corporate Restructuring Jens Ravens
PRESS RELEASE

published on 04/30/2024 at 15:00, 6 months 20 days ago

Epigenomics AG: Executive Board member Jens Ravens leaves the Company on April 30, 2024
Epigenomics AG Executive Board member Jens Ravens leaves the Company on April 30, 2024, due to successful asset transfer to New Day Diagnostics LLC. Jens Ravens played a key role in securing the company's future

Executive Board Epigenomics AG Asset Transfer Jens Ravens New Day Diagnostics LLC
BRIEF

published on 03/14/2024 at 08:05, 8 months 7 days ago

Epigenomics AG Announces 2023 Financial Results and Strategic Restructuring

Financial Results Restructuring Epigenomics AG Holding Company Cancer Detection
PRESS RELEASE

published on 03/14/2024 at 08:00, 8 months 7 days ago

Epigenomics AG publishes financial results for fiscal year 2023
Epigenomics AG reports financial results for fiscal year 2023 including key figures and operational developments. The company undergoes restructuring measures and enters into agreements to ensure future sustainability

Financial Results Epigenomics AG Fiscal Year 2023 Restructuring Measures Business Outlook
PRESS RELEASE

published on 02/15/2024 at 10:00, 9 months 6 days ago

Epigenomics AG: Jochen Hummel appointed to the Supervisory Board to replace Heikki Lanckriet
Jochen Hummel appointed to Epigenomics AG's Supervisory Board to replace Heikki Lanckriet. Appointment effective Feb 5, 2024, enriching the Board with tax expertise

Supervisory Board Epigenomics AG Jochen Hummel Heikki Lanckriet Corporate Announcement
PRESS RELEASE

published on 01/31/2024 at 15:30, 9 months 20 days ago

Epigenomics AG: Supervisory Board of Epigenomics AG appoints Hansjörg Plaggemars as member of the Executive Board
Epigenomics AG appoints Hansjörg Plaggemars as member of the Executive Board, bringing extensive management experience and finance expertise

Executive Board Supervisory Board Epigenomics AG Hansjörg Plaggemars Finance Expertise
PRESS RELEASE

published on 01/26/2024 at 13:16, 9 months 26 days ago

Epigenomics AG: Resignation of Supervisory Board Member Dr Heikki Lanckriet (PhD)
Dr. Heikki Lanckriet (PhD) resigns as a member of Epigenomics AG's Supervisory Board effective February 22, 2024. The board will seek a suitable successor as per statutory provisions.

Resignation Supervisory Board Epigenomics AG Dr. Heikki Lanckriet Corporate News
PRESS RELEASE

published on 10/30/2023 at 15:49, 1 year ago

EQS-Adhoc: Epigenomics AG: Executive Board member Jens Ravens leaves the Company on April 30, 2024
PRESS RELEASE

published on 10/10/2023 at 21:10, 1 year 1 month ago

Epigenomics AG Announces Closing of Agreement on the Acquisition of Almost All of the Company's Assets and Adjustment of Guidance for 2023
PRESS RELEASE

published on 10/10/2023 at 20:56, 1 year 1 month ago

EQS-Adhoc: Epigenomics AG: Closing of Agreement on the Acquisition of Almost All Assets and Adjustment of Guidance for 2023

Accesswire

Published on 11/21/2024 at 13:30, 30 minutes ago

AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 30 minutes ago

Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 1 hour ago

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 1 hour ago

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 1 hour ago

Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 13:15, 44 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 1 hour 24 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 44 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 1 hour 53 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 1 hour 59 minutes ago

Holding(s) in Company

Les Echos

Published on 11/21/2024 at 06:58, 7 hours 2 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 40 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 15 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 15 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE